Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| AMBR | Amber International | $2.52 | $0.94 | 59.50% | 79.6M | $136.6M | $1.23$13.09 |
| SMX | Smx (Security Matters) Public | $8.35 | $2.44 | 41.29% | 7.9M | $6.2M | $3.12$66,187.27 |
| MNDR | Mobile-health Network Solutions | $2.49 | $0.59 | 31.18% | 18.4M | $2.3M | $1.53$40.00 |
| LGHL | Lion Group | $7.20 | $1.57 | 27.79% | 30.4K | $15.6M | $3.93$213.20 |
| OSS | One Stop Systems | $5.84 | $1.23 | 26.68% | 2.5M | $113.0M | $1.85$7.20 |
| ARWR | Arrowhead Pharmaceuticals | $57.84 | $11.05 | 23.62% | 3M | $6.5B | $9.57$57.97 |
| SUPX | SuperX Ai Technology | $26.96 | $5.01 | 22.84% | 201.6K | $590.3M | $2.75$76.50 |
| LYRA | Lyra Therapeutics | $3.51 | $0.63 | 21.88% | 393.8K | $5.1M | $2.84$37.50 |
| VRCA | Verrica Pharmaceuticals | $6.23 | $1.11 | 21.58% | 610.8K | $48.6M | $3.28$13.60 |
| IRWD | Ironwood Pharmaceuticals | $3.80 | $0.67 | 21.41% | 3.1M | $509.2M | $0.53$5.13 |
Related Articles
Featured Article
A Quiet AI Stock -- SuperX AI Technology (SUPX) -- Is Up Over 770% in 2025. Here's 1 Key Reason Why It's Getting Attention.
Selena Maranjian|Nov 24, 2025
This company is a very early-stage AI business. It could skyrocket over the coming years, but it might not.
This Undervalued Stock Is Up Over 1,000% This Year. Here's 1 Key Reason Why the Run May Continue
Manali Pradhan, CFA|Nov 9, 2025
Picking a small stake in early stage AI infrastructure players can prove a smart move for investors with above-average risk appetite.
This Small AI Stock Has Outpaced Nvidia. 1 Reason Why It's Still Rising.
Stefon Walters|Oct 22, 2025
This company's path to profitability is getting a lot clearer.
This Pet Stock Is in the Doghouse, but Right Now Could Be a Golden Buying Opportunity
Jeremy Bowman|Dec 3, 2023
Petco stock tumbled on its recent earnings report, but the stock looks too cheap to ignore.
Down 7% in 2023, This Struggling Growth Stock Could Soon Make a Turnaround
Alex Carchidi|Jun 12, 2023
Ironwood's plan to purchase a smaller biotech should address some issues that have shareholders concerned.
Is Arrowhead Pharmaceuticals a Buy Now?
Cory Renauer|Apr 16, 2023
The clinical-stage drug developer is attracting a lot of positive attention from investment bank analysts.
2 Biotech Stocks That Could Soar by 130% and 92%, According to Wall Street
George Budwell, PhD|Apr 4, 2023
Arrowhead Pharmaceuticals and Seres Therapeutics are screaming buys, according to some Wall Street analysts.
Why Are Pet Stocks Going to the Dogs Again?
Rick Munarriz|Mar 23, 2023
Petco and Chewy tumbled this week after posting problematic earnings guidance. Other pet stocks are feeling the pressure.
3 No-Brainer Stocks to Buy Right Now for Less Than $25
James Halley|Feb 4, 2023
All three healthcare stocks are showing solid long-term potential.
